37P Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patientsNatalie Cook, Van K. Morris, R. Garcia-Carbonero et al.|Annals of Oncology|2024Cited by 5
391P Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in patients with pancreatic and biliary tract cancerJ.A. Bridgewater, Juan W. Valle, L. Chantrill et al.|Annals of Oncology|2024Cited by 2